<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Joel Johansson | Ruth Palmer Lab</title><link>https://deploy-preview-3--ruthpalmerlab.netlify.app/author/joel-johansson/</link><atom:link href="https://deploy-preview-3--ruthpalmerlab.netlify.app/author/joel-johansson/index.xml" rel="self" type="application/rss+xml"/><description>Joel Johansson</description><generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en-us</language><image><url>https://deploy-preview-3--ruthpalmerlab.netlify.app/author/joel-johansson/avatar_hu67c13af330c5af2d5a32c5e81e954420_4509_270x270_fill_lanczos_center_3.png</url><title>Joel Johansson</title><link>https://deploy-preview-3--ruthpalmerlab.netlify.app/author/joel-johansson/</link></image><item><title>ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition</title><link>https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/atri2/</link><pubDate>Tue, 02 Jan 2024 00:00:00 +0000</pubDate><guid>https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/atri2/</guid><description/></item></channel></rss>